Biotech News

Annual market research event starts next week in South San Francisco
KRISHGEN BIOSYSTEMS , today announced that, it has successfully developed the first commercial testing kit for detection of Nipah Virus based on the ELISA platform. The three kits can be used to detected the Nipah virus antigen and the IgG / IgM...
With over two-hundred different types of cancers, and is one of the leading causes of death, the medical world is anxiously striving to find a solution to decrease the fatality rate. In recent years, there have been advancements towards cancer treatment..
Pharmacogenomics is the relationship between a patients unique genetic makeup and their response to certain medications. Pharmacogenomics aims to optimize ones experience when treating a condition with medication, regarding the patients genotype, to...
2Market Information Inc., a publisher of Industry-Sponsored Research Management newsletter, recently celebrated the one-year anniversary of its launch, when it became and remains the first and only how-to newsletter designed to help universities attract..
Mr. Greg Hughes has been named today, National Sales Director of RGR Medical Porducts replacing William Mastro who is retiring. Mr. Hughes is a 20+ year pharmaceutical industry veteran.
Register before May 25 to get the best price for returning West Coast event
RGR Medical Products has begun the the initial stage of a private placement memorandum to raise capital for its new sleeping aid product SleepEEZE. SleepEEZE is a patent pending over the counter supplement supporting sleep.
ERLANGER, Ky. - May 16, 2018 - -- LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr. Keith Lavery...
LAWRENCE, Mass. - May 8, 2018 - -- Rubix LS is announcing today the launch of it's new Data & Research division to its core business function.  This is a step for Rubix LS to strongly position its expertise base to move as a technological think..
INDIANAPOLIS - April 27, 2018 - -- RGR Medical products as entered into an exclusive agreement to distribute NeuroZen Rehabilitation Technologies two new diabetic neurological pain management products. According to CEO of NeuroZen, Ronald Reed, a West...
LONDON - April 17, 2018 - -- PARTNERS4ACCESS has announced the appointment of Alison Kneen as Vice President of International Operations to lead its rapidly expanding Market Access Orphan Drug Specialist team.
SAN FRANCISCO - April 4, 2018 - -- Tridiagonal Solutions Inc,  provides process performance enhancement and product development solutions to worldwide clients, will be hosting a Live Two Day Training Event for Process Industry Professionals on...
Three leading British biotechnology businesses have obtained grant funding from Innovate UK to investigate the manufacture of a new class of medicines, targeting a range of clinical conditions through interaction with the human microbiome.
New office accommodates higher headcount reflecting rapid growth for both companies
10107862
Aspyron Inc. announces a Tier II qualified offering under SEC Regulation A+ of up to 2,500,000 shares of common stock at a price of $.40 per share raising up to $1,000,000
10106561
SUMMIT COUNTY, Colo. - Feb. 7, 2018 - -- Keystone Symposia is pleased to announce that it will host a free ePanel discussion on the topic of "Tech Transfer for Medical Advances: Challenges and Opportunities Commercializing Academic Biomedical Research"...
DICKINSON, N.D. - Feb. 7, 2018 - -- Trial Runners, LLC, is pleased to announce the opening of two, new global locations.
Drugshoppe, a high-performance therapeutics development collective, adds medicinal chemist Dr. Eric Kumar and Rice University Chemical Engineering student Devon DeBalsi to its cadre of researchers.
After a relatively quiet year for mergers and acquisitions in 2017, PD Wealth Solutions' Paul Graham predicts this year will produce a bumper harvest of deals between 'Big Pharma' and Biotech.
After a relatively quiet year for mergers and acquisitions in 2017, PD Wealth Solutions' Paul Graham predicts this year will produce a bumper harvest of deals between 'Big Pharma' and Biotech.